Your browser doesn't support javascript.
Coronavirus drugs: Using plasma from recovered patients as a treatment for COVID-19.
Alzoughool, Foad; Alanagreh, Lo'ai.
  • Alzoughool F; Department of Laboratory Medical Sciences, Faculty of Applied Medical Sciences, The Hashemite University, Jordan.
  • Alanagreh L; Department of Laboratory Medical Sciences, Faculty of Applied Medical Sciences, The Hashemite University, Jordan.
Int J Risk Saf Med ; 31(2): 47-51, 2020.
Article in English | MEDLINE | ID: covidwho-98445
ABSTRACT
The ongoing COVID-19 pandemic has infected nearly 3,582,233 individuals with 248,558 deaths since it was first identified in human populations in December 2019 in Wuhan, China. No antiviral therapies or vaccines are available for their treatment or prevention. Passive immunization PI through broadly neutralizing antibodies that bind to the specific antigens of SARS-CoV 2 might be a potential solution to address the immediate health threat of COVID-19 pandemic while vaccines are being developed. The PI approach in treating COVID-19 is discussed herein, including a summary of its historical applications to confront epidemics.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Antibodies, Viral Topics: Vaccines Limits: Humans Language: English Journal: Int J Risk Saf Med Year: 2020 Document Type: Article Affiliation country: JRS-201017

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Antibodies, Viral Topics: Vaccines Limits: Humans Language: English Journal: Int J Risk Saf Med Year: 2020 Document Type: Article Affiliation country: JRS-201017